Skip to Main Content
Capabilities / Healthcare Private Equity

Healthcare Private Equity

Integrating deal-making know-how with regulatory expertise to create value in healthcare private equity transactions.

In addition to the customary risks involved in private equity transactions, healthcare industry deals are subject to substantial regulatory risks that can quickly erode the value of a transaction. Husch Blackwell’s dedicated team of healthcare private equity lawyers bring together two crucial skill sets to help private equity firms and their portfolio companies maintain and enhance value: a nationally recognized group of healthcare regulatory lawyers who understand the real costs of compliance and a veteran group of dealmakers who have comprehensive knowledge of the design and structure of private equity-backed transactions and can provide buy- and sell-side advice at all stages.

Our clients typically involve our team early on in a deal scenario, allowing our lawyers to explore and test how a prospective deal’s financial and operational models stand up to a deep, thorough evaluation of the target asset and the regulatory framework in which a deal might occur. Our team goes beyond routine fact-checking and box-ticking—we are active collaborators with our clients in evaluating potential deals and providing advice on how to address challenges to the deal process as they emerge.

Our private equity lawyers have handled over 25 healthcare private equity deals in the healthcare and life science spaces in the last three years, with an aggregate value of more than $1.6 billion. Our clients include private equity funds and their portfolio companies, as well as healthcare providers and life science companies seeking investments from private equity sponsors. Our experience extends across the entire spectrum of care, including physician groups, hospitals, pharmacies, post-acute care facilities, behavioral health providers and medical device and life science companies, among others.

Our team is frequently called on to:

  • Structure, negotiate and implement leveraged buy-outs, divestitures and growth equity financings;
  • Structure portfolio operating and holding entities to limit liability and accommodate financing and growth;
  • Introduce our clients to strategic financing partners;
  • Structure equity participation incentives for portfolio company management;
  • Minimize tax burdens on cash flow;
  • Structure and document joint ventures; and
  • Counsel clients on the complicated regulatory landscape of the healthcare industry.
News Releases | April 10, 2020
Wakaba Tessier Named to Law360 2020 Health Editorial Advisory Board

Tessier will serve as one of 10 subject-matter experts who will offer feedback and insight on Law360's health coverage.

Testimonials Usman Mirza, CEO, The San Antonio Orthopaedic Group

“The team at Husch Blackwell knows our industry. From negotiating agreements to helping us with strategic decision-making, the Healthcare team is always responsive and exceeds expectations.”

Read how invested partnerships make a difference
Testimonials Mark Baker, CEO, Jack Hughston Memorial Hospital and The Hughston Clinic

“We can always count on the team at Husch Blackwell to help us with business and operational challenges so that we can focus on caring for our patients and being innovative.”

Read how invested partnerships make a difference
Client Results

A digest of healthcare private equity matters.

See examples from previous projects

Stay updated.

Subscribe to receive Husch Blackwell’s news and insights.

Select your preferences